
United States · Biotechnology Research startup
StemoniX is a biotechnology company that focuses on stem cell technologies to meet the demands of drug discovery and personalized medicine.
Funding reportedLast round: Convertible note
Funding, as reported
From StemoniX's own website and the SEC filings it signed: 6 on the team.
On the board, as filediKevin GundersonPatrick O'ShaughnessyPaul HansenSriram Nadathur
Add your raise, your deck and your story, and put StemoniX in front of investors. Or tell us what we have wrong.